Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson’s disease (Q50553843)

15 March 2018

reason for preferred rank

title

Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson’s disease (English)

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

3 September 2024

Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21109502

3 September 2024

1 reference

Lirong Jin

1

1 reference

15 March 2018

Jian Wang

2

1 reference

15 March 2018

Lei Zhao

3

1 reference

15 March 2018

Hang Jin

4

1 reference

15 March 2018

Guoqiang Fei

5

1 reference

15 March 2018

Yuwen Zhang

6

1 reference

15 March 2018

Mengsu Zeng

7

1 reference

15 March 2018

Chunjiu Zhong

8

1 reference

15 March 2018

language of work or name

English

0 references

publication date

24 November 2010

1 reference

15 March 2018

full work available at URL

https://academic.oup.com/brain/article-pdf/134/1/50/16696675/awq319.pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21109502

http://brain.oxfordjournals.org/cgi/content/abstract/134/1/50

3 September 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21109502

http://academic.oup.com/brain/article-pdf/134/1/50/16696675/awq319.pdf

3 September 2024

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

3 September 2024

1 reference

15 March 2018

volume

134

1 reference

15 March 2018

issue

Pt 1

1 reference

15 March 2018

page(s)

50-58

1 reference

15 March 2018

Iron metabolism in Parkinsonian syndromes

cites work

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Increased nigral iron content in postmortem parkinsonian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Diagnostic criteria for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Imaging iron stores in the brain using magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Susceptibility weighted imaging (SWI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

The effect of age on the non-haemin iron in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Aceruloplasminemia: molecular characterization of this disorder of iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Biochemical aspects of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Iron metabolism in copper-deficient swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Genetics of iron regulation and the possible role of iron in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Potential role of high-field MRI for studies in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Iron, brain ageing and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis

21 January 2018

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

1

1 reference

Functional relevance of ceruloplasmin mutations in Parkinson's disease

3 September 2024

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

17

1 reference

Hypoceruloplasminemia-related movement disorder without Kayser-Fleischer rings is different from Wilson disease and not involved in ATP7B mutation

3 September 2024

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

21

1 reference

Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions

3 September 2024

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

22

1 reference

Quantification of punctate iron sources using magnetic resonance phase.

3 September 2024

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

23

1 reference

Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury.

3 September 2024

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

27

1 reference

Ceruloplasmin in neurodegenerative diseases

3 September 2024

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

32

1 reference

Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease

3 September 2024

https://api.crossref.org/works/10.1093/BRAIN/AWQ319

35

1 reference

3 September 2024

Identifiers

DOI

10.1093/BRAIN/AWQ319

1 reference

15 March 2018

1 reference

15 March 2018